Picture of Chimerix logo

CMRX — Chimerix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Chimerix Inc reports results for the quarter ended in September - Earnings Summary

* Chimerix Inc  CMRX.OQ  reported a quarterly adjusted loss
of 27
cents​​ per share for the quarter ended in September, lower than
the same quarter last year, when the company reported EPS of
$2.75.  The mean expectation of seven analysts for the quarter
was for a loss of 23 cents per share. Wall Street expected
results to range from -26 cents to -20 cents per share.
    * Revenue fell 100% to $11.00 thousand from a year ago;
analysts
expected $76.43 thousand. 
    * Chimerix Inc's reported EPS for the quarter was a loss
of 27
cents​.
    * The company reported a quarterly loss of $23.8 million.
    * Chimerix Inc shares had risen by 0.0% this quarter and
lost 48.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Chimerix
Inc is
$7.00 

This summary was machine generated from LSEG data November 2 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.23          -0.27          Missed
 Jun. 30 2023      -0.24          -0.21          Beat
 Mar. 31 2023      -0.25          -0.24          Beat
 Dec. 31 2022      -0.24          -0.24          Met

Recent news on Chimerix

See all news